Semaglutide for Weight Loss: How It Works

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as a transformative option for weight management, with clinical trials showing an average weight loss of 15% over 68 weeks in patients without diabetes. This medication works by activating receptors that regulate hunger and blood sugar, making sustainable weight loss more achievable than diet and exercise alone. Understanding how semaglutide functions can help you decide if it aligns with your health goals.

How Semaglutide Works to Support Weight Loss

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your gut naturally produces after eating. When you inject semaglutide, it binds to GLP-1 receptors in your brain's appetite center, reducing the hunger signal and increasing feelings of fullness. This mechanism is why patients often report eating smaller portions without feeling deprived or struggling with cravings.

Beyond appetite suppression, semaglutide slows how quickly your stomach empties food into your intestines. This delayed gastric emptying means nutrients enter your bloodstream more gradually, keeping your blood sugar stable and extending the satiety window after meals. The combination of reduced hunger hormones and prolonged fullness creates a powerful metabolic shift that supports consistent weight loss over months.

Clinical Evidence Behind Semaglutide Effectiveness

The STEP trials, which included over 4,500 participants, demonstrated that semaglutide recipients lost significantly more weight than those on placebo. Participants receiving the highest dose lost an average of 50+ pounds over 68 weeks, with improvements in waist circumference and metabolic markers like fasting glucose and cholesterol. These results represent some of the most robust weight loss data in pharmaceutical history.

Weight loss with semaglutide typically follows a predictable pattern: most patients see noticeable changes within 4-8 weeks, with steady progress continuing through 6 months of treatment. Long-term studies show that weight loss plateaus around the 12-month mark, but most patients maintain their achieved weight loss as long as they continue treatment. Individual results vary based on genetics, diet, activity level, and medication adherence.

Personalized Semaglutide Dosing at PlexusDx

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility for injection therapy. Your dose may need to go up as your body adjusts and your provider optimizes your treatment—your price won't. Starting at $149 per month, PlexusDx pricing remains flat whether you're at a microdose or a therapeutic dose, removing financial barriers to reaching your optimal weight loss dose.

Semaglutide injections are administered once weekly, making adherence straightforward compared to daily medications. PlexusDx serves all 50 states without requiring insurance, and your treatment qualifies for HSA and FSA accounts. Patients interested in genetic insights can add the PlexusDx Precision Peptide Genetic Test after their first month to understand how variants in the GLP1R gene and other peptide pathways influence their individual response to semaglutide therapy.

Common Side Effects and Safety Considerations

The most frequently reported side effects of semaglutide are gastrointestinal: nausea, vomiting, constipation, and diarrhea occur in a dose-dependent manner, meaning higher doses carry greater risk. Nausea typically appears early in treatment and often diminishes within 2-4 weeks as your body adapts. Starting at a low dose and increasing gradually (a practice called titration) significantly reduces the severity and duration of side effects.

Rare but serious concerns include pancreatitis, gallbladder problems, and thyroid effects—though these occur in less than 1% of users and are often reversible upon discontinuation. Semaglutide is not recommended for patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. PlexusDx providers review your complete medical history before prescribing to ensure semaglutide is safe and appropriate for your individual health profile.

Semaglutide vs. Other GLP-1 Options for Weight Loss

Semaglutide is one of several GLP-1 agonists available, but it stands apart for its once-weekly injection frequency and robust clinical evidence in non-diabetic weight loss populations. Other GLP-1 medications like liraglutide require daily injections, while oral semaglutide offers an alternative delivery method at a higher monthly price point. PlexusDx offers both compounded semaglutide injection ($149/month) and oral semaglutide ($249/month), allowing you to choose based on preference and lifestyle.

If you're exploring stronger outcomes, PlexusDx also offers tirzepatide, a dual GLP-1/GIP receptor agonist that targets two appetite pathways simultaneously and has shown weight loss of up to 22% in clinical trials. The choice between semaglutide and tirzepatide depends on your weight loss goals, tolerance for side effects, and genetic predispositions—another reason why the PlexusDx Precision Peptide Genetic Test can inform your treatment selection.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 15-18% of body weight over 68 weeks, though individual results range from 5-50+ pounds depending on starting weight, adherence, diet, and exercise. Your genetics also play a role—the PlexusDx Precision Peptide Genetic Test examines your GLP1R gene variant to predict your likely response trajectory.

How quickly does semaglutide start working?

Most patients notice reduced hunger and smaller appetites within 1-2 weeks of starting semaglutide, though measurable weight loss typically appears by week 4. Progressive weight loss accelerates through months 2-6 as your dose increases and your body adapts. Full effects are usually realized by 3-6 months of consistent treatment.

Why is PlexusDx semaglutide more affordable than brand-name options?

PlexusDx offers compounded semaglutide from licensed 503A pharmacies at $149 per month, well below brand-name prices, with no insurance required and HSA/FSA eligibility. Your dose may increase without price increases—a pricing model designed to remove barriers to reaching your therapeutic dose.

Are there genetic factors that influence how well semaglutide works?

Yes—your GLP1R gene rs6923761 variant significantly influences how sensitively your appetite receptors respond to semaglutide. The PlexusDx Precision Peptide Genetic Test analyzes this variant plus 48 other peptides across 14 metabolic pathways to predict your personalized response and guide dose optimization.

What happens if I stop taking semaglutide?

Weight loss plateaus within 2-4 weeks of stopping semaglutide, and gradual weight regain typically occurs over months as hunger hormones normalize. Most patients regain 50-70% of lost weight within 1-2 years after discontinuation, which is why semaglutide is considered a long-term treatment rather than a short-term intervention.

Understanding the Value of Semaglutide in Your Weight Loss Journey